The Immunization and Vaccines Development Programme provides technical support to countries in the African Region in order to contribute to the reduction of disease, disability and death due to vaccine preventable diseases.
Brazzaville, 6 September 2016 – The largest emergency vaccination campaign against yellow fever ever attempted in Africa, came to an end on 5 September 2016 with more than 10.6 million people in the Democratic Republic of Congo (DRC) vaccinated against the lethal disease.
|Ministers pledge to improve access to vaccines at first-ever Ministerial Conference on Immunization in Africa|
|Addis Ababa, 25 February 2016 – With one in five African children lacking access to all needed and basic life-saving vaccines, ministers of health and other line ministers countries committed themselves to keep immunization at the forefront of efforts to reduce child mortality, morbidity and disability.|
At a landmark Ministerial Conference on Immunization in Africa held from 24-25 February, in Addis Ababa, Ethiopia the ministers signed a declaration to promote the use of vaccines to protect people of all ages against vaccine-preventable diseases and to close the immunization gap by 2020.
|Meningitis A nearly eliminated in Africa through vaccination, reaching more than 235 million people|
Addis Ababa, 23 February 2016 - Global vaccine experts and officials from all 26 African “meningitis belt” countries have convened in Addis Ababa, Ethiopia to celebrate one of Africa’s biggest public health achievements—the introduction of a vaccine, MenAfriVac®, designed, developed, and produced for use in Africa, that in five years of use has nearly eliminated serogroup A meningococcal disease from meningitis belt countries and is now being integrated into routine national immunization programs.
24 - 30 April 2017
Ministerial Conference on Immunization in Africa
24 - 25 February 2016
Addis Ababa, Ethiopia